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Abstract
Rationale: Cystic fibrosis (CF) airways disease produces a
mucoobstructive lung phenotype characterized by airways mucus
plugging, epithelialmucouscellmetaplasia/hyperplasia, chronic infection,
and inflammation. Simultaneous biochemical and functional in vivo
studiesofmucinsynthesisandsecretionfromCFairwaysarenotavailable.
In vitro translationalmodelsmayquantitate differentialCFversusnormal
mucin and fluid secretory responses to infectious/inflammatory stimuli.
Objectives:We tested the hypothesis that CF airways exhibit
defective epithelial fluid, but not mucin, secretory responses to
bacterial/inflammatory host products.
Methods:Well-differentiated primary human bronchial epithelial
cultures were exposed to supernatant from mucopurulent material
(SMM) from human CF airways as a test of bacterial/inflammatory
host product stimulus. Human bronchial epithelia (HBE) with
normal CF transmembrane conductance regulator function were
compared with DF508/DF508 CF HBE.
Measurements and Main Results: Acute (up to 60 min)
SMM exposure promoted mucin secretion, but mucins were
degraded by the proteolytic enzymes present in SMM. Chronic
SMM exposure induced upregulation of mucin synthesis and
storage and generated absolute increases in basal and stimulated
mucin release in normal and CF cultures. These responses
were similar in normal and CF cultures. In contrast,
SMM produced a coordinated CF transmembrane
conductance regulator–mediated Cl2 secretory response in
normal HBE, but not in CF HBE. The absence of the
fluid secretory response in CF produced quantitatively more
dehydrated mucus.
Conclusions:Our study reveals the interplay between regulation of
mucin and fluid secretion rates in inflamed versus noninflamed
conditions and why a hyperconcentrated mucus is produced in CF
airways.
Keywords: cystic fibrosis; airway mucins; airway hydration;
airway inflammation
Cystic fibrosis (CF) is a mucoobstructive
airways disease characterized by chronic
mucus accumulation, infection, and
inflammation. CF is believed to exhibit an
element of failed mucus transport that
contributes to disease pathogenesis. Mucins
are the major components of airway mucus
that generate the biophysical properties that
support mucus transport (1, 2). Secretory
cells in mammalian airways produce two
polymeric mucins, MUC5AC and MUC5B,
large glycoproteins that comprise the
polymer scaffold of the mucus gel (3).
In healthy subjects, and in those with
mucoobstructive disease, acute insults
promote rapid secretion of mucins onto
airway surfaces via exocytosis of mucin
granules (4). Persistent exposure to airway
insults induces increased synthesis of airway
mucins associated with an increased number
of mucin-producing cells (5). Although
mucin secretion is essential for clearance in
normal airways (6), it may be maladaptive in
airways of subjects with CF (7–9). In these
subjects, bacterial exoproducts and
inflammatory mediators promote mucous
cell hyperplasia/metaplasia and upregulate
(Received in original form June 9, 2017; accepted in final form November 3, 2017 )
Supported by grants from the Cystic Fibrosis Foundation (ABDULL04G0 [L.H.A.], RIBEIR07G0 [C.M.P.R.], and MCC DAVIS07XX0 [C.W.D.]) and NIH
(P30DK065988, P01HL108808, P01HL110873, and R01HK103940 [R.C.B.] and R01HL103940 [M.K.]).
Author Contributions: L.H.A., R.C., Y.Z., R.T., M.J.W., G.R., and M.K. performed the experiments. L.H.A., R.C.B., C.W.D., and C.M.P.R. designed the study.
L.H.A., R.C., R.T., M.J.W., and C.M.P.R. analyzed the data. L.H.A., R.C.B., and C.M.P.R. drafted and finalized the manuscript.
Correspondence and requests for reprints should be addressed to Carla M. P. Ribeiro, Ph.D., 125Mason Farm Road, 1111Marsico Hall, Chapel Hill, NC 27599-
7248. E-mail: carla_ribeiro@med.unc.edu.
This article has an online supplement, which is accessible from this issue’s table of contents at www.atsjournals.org.
Am J Respir Crit Care Med Vol 197, Iss 4, pp 481–491, Feb 15, 2018
Copyright © 2018 by the American Thoracic Society
Originally Published in Press as DOI: 10.1164/rccm.201706-1139OC on November 3, 2017
Internet address: www.atsjournals.org
Abdullah, Coakley, Webster, et al.: Stimulated Mucus Production in Normal vs. CF Airways 481
 
mucin synthesis and secretion (5, 10).
In airways expressing normal CF
transmembrane conductance regulator
(CFTR) function, these insults coordinately
promote increased CFTR-mediated fluid
secretion to hydrate mucus and promote
mucus-dependent clearance. The lack of
functional CFTR in CF leads to airway
surface dehydration, producing mucus
hyperconcentration and mucus
stasis/adhesion (10).
The present study investigated the
integrated mucin and fluid secretory responses
to the intralumenal mucopurulent materials
that characterize the chronic mucoobstructive
state of CF airways. Primary cultures of
well-differentiated normal (non-CF) human
bronchial epithelia (HBE) versus CFHBEwere
exposed to a supernatant of mucopurulent
material (SMM) from human CF airways
(11, 12). SMM contains the soluble infectious
and inflammatory components present in the
lumens of CF airways associated with chronic
infection (13, 14). The acute versus chronic
effects of SMM on MUC5AC and MUC5B
transcription, translation, secretion, and
proteolysis were compared in normal versus
CF cultures. The impact of CFTR function on
ion and fluid transport responses to SMMwas
also investigated in normal versus CF HBE to
characterize the integrated effects of hydration
on the properties of mucus (i.e., percent
solids), which governs mucus transport
rates.
Methods
For further details on the applied METHODS,

































































Figure 1. Acute supernatant of mucopurulent material (SMM) exposure induces mucin release and
promotes degradation of secreted mucins. After washing away accumulated mucins, non–cystic
fibrosis (normal) human bronchial epithelial cultures were mucosally exposed to various doses of
SMM for 1 hour. Secreted mucins were collected from the epithelial surface and the cultures were
fixed. (A) Alcian blue/periodic acid–Schiff (AB/PAS) staining of human bronchial epithelial cultures
exposed to phosphate-buffered saline (control), 100-mM ATPgS, or various doses of SMM. ATPgS
was used as a positive control for mucin release. (B) Quantification of the dose-dependent effect of
acute SMM-promoted mucin exocytosis. (C) Secreted mucin levels (measured by ELISA) from the
cultures depicted in A. Data represent mean6 SD; n = 4–5. *P, 0.05, ATPgS-treated or SMM-
exposed versus control cultures. Scale bar = 20 mm. ATPgS = adenosine 59-O-(3-thio)triphosphate.
At a Glance Commentary
Scientific Knowledge on the
Subject: Simultaneous biochemical
and functional in vivo studies of mucin
synthesis and secretion from cystic
fibrosis (CF) airways are not available.
In vitro translational models
quantitating differential CF versus
normal mucin and fluid secretory
responses to infectious/inflammatory
stimuli have not been developed.
What This Study Adds to the
Field: The integrated mucin and fluid
secretory responses to the intralumenal
mucopurulent materials that
characterize the mucoobstructive state
of CF airways were investigated in
primary cultures of normal and CF
human bronchial epithelia. Normal
airways mounted an adapted response
that included increased MUC5AC and
MUC5B secretion and robust CF
transmembrane conductance
regulator–mediated fluid secretion, to
produce a dilute mucus to “flush”
toxicants from airway surfaces. CF
airways exhibited similar increases in
mucin secretion but failed to secrete
fluid, producing an inappropriately
hyperconcentrated mucus that
contributes to airway obstruction.
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Human Bronchial Epithelial Culture
and Mucopurulent Materials from CF
Airways
Normal human bronchial epithelial cells
were isolated from excised non-CF lungs
rejected for transplant by local and distant
organ procurement agencies; HBE from
DF508/DF508 CF lungs were obtained at the
time of a transplant. Non-CF lungs originated
from patients with no history of inflammatory
or infectious disease known to affect the
respiratory airways. Human bronchial epithelial
cells and mucopurulent materials from the
airways of excised human CF lungs were
obtained in accordance with institutional review
board–approved protocols and provided by the
Tissue Procurement and Cell Culture Core
from the Cystic Fibrosis Center at the University
of North Carolina at Chapel Hill as previously
described (11, 12). Well-differentiated primary
non-CF and CF human bronchial epithelial
cultures were studied as previously reported
(11, 12). SMM was obtained as previously
detailed (11) and pooled from 14 CF lungs
infected with Pseudomonas aeruginosa and
Staphylococcus aureus. The SMM demographics
are shown in Table E1 in the online supplement.
Mass Spectrometry of SMM
SMM samples were subjected to mass
spectrometry–based proteomics analysis as
previously described (15).
Treatment of HBE with SMM
Before the experiments, the apically
accumulated mucus was removed with
phosphate-buffered saline (PBS). Cultures
were mucosally exposed to 30 ml PBS or
SMM at different dilutions over various
times. Apical mucus was collected as
previously reported (16). In some studies,
cultures were immediately fixed for histology.
Histology and Quantification of Mucin
Stores
Cultures were fixed in 10% formalin and
embedded in paraffin. Sections were stained
with alcian blue/periodic acid–Schiff
(AB/PAS) reagent and examined by
conventional light microscopy. The
intracellular AB/PAS-positive area (an index
of intracellular mucin stores) was quantitated




mucin antibodies used a mouse
MUC5AC antibody (MAB2011, clone
CLH2) and a rabbit MUC5B antibody
(5BVNTR-1) generated for this
study recognizing the sequence
SSPGTATALPALRSTATTPTATS. Mature
(globular protein) mucin antibodies used
1) a rabbit polyclonal that recognizes all
vertebrate polymeric mucins (18), 2) a
MUC5AC rabbit polyclonal (MAN5AC)
that recognizes the C-terminal peptide
sequence RNQDQQGPFKMC (19), and
3) a MUC5B mouse antibody (EU-MUC5Ba)
that recognizes the peptide sequence
RNREQVGKFKMC (20).
Purified Mucins
MUC5AC and MUC5B were isolated from
HT-29 cells and human saliva, respectively
(21). Mucins purified from sputum from
patients with CF were used to generate
standard curves for the ELISA assay (17).
Concentrations of purified mucins were
determined by their refractive index (16).
Analysis of Mucin Gene Expression by
qRT-PCR
These analyses were performed as
previously described (22, 23).
C









































































Figure 2. Time course for acute supernatant of mucopurulent material (SMM)-induced mucin release
and degradation of secreted mucins. (A) Alcian blue/periodic acid–Schiff (AB/PAS) staining of
non–cystic fibrosis (normal) human bronchial epithelial cultures mucosally exposed to undiluted SMM
for various amounts of time up to 60 minutes. (B) Quantification of the time-dependent effect of acute
SMM-promoted mucin exocytosis. (C) Secreted mucin levels (measured by ELISA) from the cultures
depicted in A. Apical secretions were collected in buffer containing protease and elastase inhibitors.
Cultures were fixed immediately after sample collection. Depletion of mucin stores occurs as early as
5 minutes and is almost complete by 60 minutes. Approximately 60% of secreted mucins are
degraded in 1 hour, as compared with secreted mucins after 5-minute SMM exposure. Data
represent mean6 SD. n = 5. *P, 0.05, SMM-exposed versus control cultures. Scale bar = 20 mm.
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Assessment of Mucin Protein
Extracted human bronchial epithelial
samples were dialyzed against 6-M urea
buffer, and their mucins were resolved by
electrophoresis in 1% agarose gels, and
analyzed by Western blotting (3).
Mucin Secretion
Apical secretions were collected after each
treatment (19), and mucin quantities measured
by ELISA (3, 16). For inhibition of mucin
proteolysis, a cocktail of protease inhibitors
with broad spectrum for serine, cysteine, and
metalloproteases and a specific elastase inhibitor
were added to the samples immediately after
collection. To evaluate total accumulation of
secreted mucins during 72-hour SMM
exposure, the mucosa was lavaged five times
with PBS to collect accumulated mucins.
Cultures were subsequently exposed to 100-mM
adenosine 59-O-(3-thio)triphosphate (ATPgS)
to release mucins from intracellular stores,
which were collected in 400 ml PBS. Total
mucins were measured by ELISA using the
previously mentioned mucin antibodies.
Bioelectric Studies
These were performed in HBE mounted in
Ussing chambers as previously reported (24).
Airway Surface Liquid Height
A total of 20 ml PBS or SMM containing
2 mg/ml rhodamine-dextran was added to
prewashed cultures at the start of the
experiment and airway surface liquid (ASL)
height measured with XZ confocal
microscopy as previously detailed (25).
Assessment of Mucus Percent Solids
The percentage solids of mucus from normal
and CF human bronchial epithelial cultures
was measured as previously reported (8).
Statistical Analysis
All experiments were performed on cultures
established from at least three different donors
(n> 3 independent biologic replicates). Data
are expressed as mean values6 SD, and
analyzed by ANOVA, using the GraphPad
InStat software. Statistical significance was
defined as P less than 0.05.
Results
Acute Effect of SMM on Mucin
Secretion and Degradation in Normal
(Non-CF) HBE
We first tested whether acute exposure of
normal HBE to SMM promoted mucin
secretion. Cultures were exposed to different
dilutions of SMM for 1 hour, followed by
collection of lumenal secretions (containing
residual SMM) for assessment of mucin
concentrations. As a positive control for
mucin secretion, cultures were exposed to
ATPgS, a purinergic agonist that induces
maximal mucin exocytosis (3, 4, 17).
Cultures were fixed and stained with
AB/PAS to visualize their intracellular
mucin content.
Exposure of normal human bronchial
epithelial cultures to undiluted SMM
produced a maximal discharge of mucin
stores, based on the comparability of
AB/PAS-positive intracellular content to
that following a maximal concentration of
ATPgS (Figure 1A). Dilution of SMM by a
factor of 3 elicited approximately the same
mucin discharge effect as the undiluted
material (Figure 1A). In contrast, a 10-fold





























Figure 3. Protease inhibition prevents mucin degradation by supernatant of mucopurulent material
(SMM). Mucins harvested from non–cystic fibrosis (normal) human bronchial epithelia were incubated
with different doses of SMM in presence or absence of protease inhibitors (PI) for 30 minutes.
Samples were evaluated for MUC5B, because it is the major mucin produced and secreted by human
bronchial epithelial cultures. Data represent mean6 SD. n = 3. *P, 0.05, SMM-exposed versus


































Figure 4. Dose–response for chronic supernatant of mucopurulent material (SMM) exposure on
mucin gene expression. Non–cystic fibrosis (normal) human bronchial epithelial cultures were washed
and mucosally exposed to various doses of SMM for 48 hours. Cultures were washed again and
extracted in RNeasy guanidine-based buffer, and MUC5AC and MUC5B mRNA levels were
determined by qRT-PCR. Data represent mean6 SD. n = 6. *P, 0.05, SMM-exposed versus control
cultures.
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effect on mucin exocytosis, as evidenced by
increased residual mucin storage in mucous
cells (Figure 1A). The quantification of the
dose-dependent effect of acute SMM-
promoted mucin exocytosis is depicted in
Figure 1B.
We next assessed the quantity of
mucins secreted following 1-hour exposure
to various dilutions of SMM measured by
ELISA (16) using a subunit antibody that
detects all mature polymeric mucins tested so
far (canine, bovine, mouse, rat; unpublished
data from L.H.A.). In contrast with the
histology data depicted in Figures 1A and 1B,
the quantity of secreted mucins was inversely
correlated with both SMM concentration and
intracellular stores (Figure 1C). Because
secreted mucins were in contact with SMM
for 1 hour, we speculated that proteases
present in SMM caused proteolytic
degradation of antigenic epitopes of secreted
mucins in a time-dependent manner. To
address this possibility, a time course for full-
strength SMM-induced mucin secretion was
performed, mucosal samples collected, and
cultures fixed for histologic analysis. Mucin
release occurred within 5 minutes of
undiluted SMM exposure, and the mucin
stores were fully discharged after a 30-minute
exposure (Figures 2A and 2B). Peak mucin
secretion was observed at 5 minutes,
following which a progressive reduction in
ELISA-measureable mucin was detected
(Figure 2C). These data suggest that SMM
induces a time-dependent proteolytic loss of
antigenic epitopes of secreted mucins.
To further investigate the proteolytic
degradation of secreted mucins by SMM,
secretedmucins fromnormal humanbronchial
epithelial cultures were exposed to SMM for
30 minutes in the presence or absence of
protease inhibitors. Samples were selectively
assayed for MUC5B because it is the major
mucin in human bronchial epithelial cultures
(3). SMM induced MUC5B degradation in a
dose-dependent manner, and this effect was
blunted by the addition of protease inhibitors
(Figure 3). These findings agree with previous
observations that proteolytic degradation of
mucin antigenic epitopes can be induced by
the elastase and other proteases that are
components of CF sputum (23, 26).
Because the acute stimulatory effect of
SMMonmucin secretion could be caused, at
least in part, by neutrophil elastase (27, 28),
we subjected SMM to proteomic analysis
for identification of proteases. Table E2
depicts the proteases, and protease
inhibitors, present in SMM. Several
neutrophil-derived proteases, including
neutrophil elastase, cathepsin G, and the
neutrophil metalloproteases collagenase
(metalloproteinase 8) and gelatinase
(metalloproteinase 9; MMP-9), were
identified in SMM. These proteases are
present in ASL and BAL fluid from patients
with CF (29, 30). Protease inhibitors (e.g.,
leukocyte elastase inhibitor, plasma
protease C1 inhibitor, metalloproteinase
inhibitors 1 and 2 and alpha-1 antitrypsin)
were also identified in SMM (see Table E2).
These findings are consistent with the
notion that proteases present in SMM
contributed to both mucin secretion and
proteolysis. SMM also contains nucleotides
(14) and a wide assortment of T-helper cell
type 1 cytokines (see Figure E1), which may
also contribute to mucin secretion in
inflamed airways.
Chronic Effect of SMM on Mucin
Synthesis and Secretion
Chronic SMM-induced mucin production
was studied at 48 and 72 hours because



































































































































Figure 5. Dose–response for chronic supernatant of mucopurulent material (SMM) exposure on
MUC5AC and MUC5B protein synthesis. Non–cystic fibrosis (normal) human bronchial epithelial
cultures were washed and mucosally exposed to different dilutions of SMM for 48 hours. Cultures
were extracted in RNeasy guanidine-based buffer, and aliquots electrophoresed in agarose.
Immunoblots were probed with antibodies to the immature and mature forms of MUC5AC (A and B)
and MUC5B (C and D). Data represent mean6 SD. n = 5–6. *P, 0.05, SMM-exposed versus control
cultures.
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SMM-induced mucous cell metaplasia was
evident at 48 hours and maximal at 72 hours
(data not shown). SMM promoted large
increases in MUC5AC and MUC5B mRNA
levels at 48 hours in a dose-dependent
manner (Figure 4). Whole cell extracts from
48-hour SMM-treated cultures revealed
that SMM exposure for 48 hours stimulated
production of both the immature and
mature forms of MUC5AC and MUC5B,
an effect dependent on SMM dilution
(Figure 5).
The upregulation of the mRNA and
protein production levels of MUC5AC and
MUC5B observed at 48 hours with
undiluted SMM exposure was maintained
at 72 hours, but a few differences were
noted (Figure 6). First, the relative levels of
MUC5AC mRNA waned substantially at
72 hours versus 48 hours with undiluted
SMM exposure (Figure 4), producing a
relatively greater increase in MUC5B
versus MUC5AC mRNA at 72 hours
(Figure 6). Second, whereas there were no
significant changes in the relative levels of
immature MUC5AC and MUC5B protein
between 48- and 72-hour SMM exposure
(Figures 5 and 6), the levels of both mature
MUC5AC and MUC5B protein increased
after 72-hour SMM exposure (compare
Figure 6 with Figure 5). The upregulation
of the level of mature MUC5B was
greater than mature MUC5AC, perhaps
reflecting the fact that human bronchial
epithelial cultures typically express more
MUC5B than MUC5AC (3).
We next compared the mucin secretory
responses of normal versus CF HBE with
chronic (72 h) SMM exposure to mimic the
chronic exposure that occurs in vivo
(Figure 7). Unlike our previous report (3),
MUC5AC, but not MUC5B, secretion rates
were greater under basal conditions in CF
than normal cultures. We speculate that
this difference may reflect variable
epigenetic regulation of MUC5AC
expression that can be manifest in CF
cultures (31).
With respect to responses to an
inflammatory challenge, 72-hour SMM
increased secretion of MUC5AC and
MUC5B equally in both non-CF and CF
cultures (Figure 7). Indeed, chronic
exposure to SMM produced an equivalent
upregulation of mucin biosynthesis, mucin
secretion, and lumenal accumulation of
mucins in both normal and CF HBE. We
speculate that, unlike the acute SMM
exposure, the proteolytic capacity of SMM
was overwhelmed by the SMM-induced
mucin overproduction/secretion in both
non-CF and CF cultures.
Characterization of Ion Transport
Responses to SMM
Bioelectric studies were conducted in
normal and CF HBE lumenally exposed to
PBS or SMM for 72 hours. In the absence
of SMM, the amiloride-sensitive current
was higher in CF versus non-CF cultures
(Figures 8A and 8B). Notably, SMM
exposure decreased the amiloride-sensitive
current in normal cultures, whereas it
did not change the amiloride-sensitive
current in CF cultures (Figures 8A and
8B). Forskolin-induced Cl2 secretory
currents were present in PBS-exposed
normal HBE, whereas they were absent
in CF HBE (Figures 8A and 8B).
Importantly, the forskolin-induced
current in normal cultures was doubled
by the SMM treatment (Figure 8A). In
contrast, there was no induction of
forskolin stimulated Cl2 secretory
channels in CF HBE exposed to SMM,
consistent with the lack of functional
CFTR activity in the CF cultures
(Figure 8B). Moreover, SMM potentiated
uridine-59-triphosphate–induced currents,
which reflect a calcium-mediated response,
in both normal and CF HBE (Figures 8A
and 8B), in agreement with previous
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Figure 6. Effect of chronic (72 h) supernatant of mucopurulent material (SMM) treatment on
MUC5AC and MUC5B mRNA and protein levels. Non–cystic fibrosis (normal) human bronchial
epithelial cultures were washed and mucosally exposed to undiluted SMM for 72 hours. Cultures
were extracted in RNeasy guanidine-based buffer. Aliquots were either used for determination of
MUC5AC and MUC5B mRNA levels by qRT-PCR (A) or electrophoresed in agarose for evaluation of
the immature and mature forms of MUC5AC (B) and MUC5B (C). (D) Compiled data expressed as fold
change of SMM/phosphate-buffered saline from the experiments illustrated in B and C. Data represent
mean6 SD. n= 6–8. *P, 0.05, SMM-exposed versus control (phosphate-buffered saline) cultures.
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inflammation expands the endoplasmic
reticulum calcium stores, resulting in an
upregulation of calcium-mediated
responses (11, 12). The compiled data
depicting differences in amiloride-
sensitive, and forskolin- and uridine-59-
triphosphate–induced currents in normal
and CF HBE are shown in Figure 8C.
The effect of SMM to increase
forskolin-induced currents in non-CF
cultures was additionally addressed in time
course and dose–response studies for SMM.
Forty-eight-hour SMM exposure promoted
maximal increases in forskolin-induced
currents, and this effect was dose
dependent (see Figure E2).
ASL Volume Responses to SMM
To directly address the impact of SMM
regulation of ion transport on airway
hydration, ASL height was measured in
normal and CF HBE exposed to SMM for
72 hours. As compared with PBS
administration, SMM robustly increased
ASL height in normal cultures but had no
effect on ASL height in CF cultures
(Figure 9A). Mucosal addition of CFTRInh-172
to normal HBE blocked the SMM-induced
increase in ASL height, consistent with
a CFTR-dependent fluid secretory
mechanism (Figure 9B). Taken together,
these findings indicate that in normal
airway epithelia with functional
CFTR, the upregulation of mucin
production/secretion resulting from
infection/inflammation is accompanied
by a robust CFTR-mediated airway
hydration.
Mucus Hydration Responses to SMM
We next evaluated the impact of 72-hour
SMM on the percent of secreted mucus
solids in normal and CF cultures. Exposure
of normal HBE to SMM decreased the
percent solids of secreted mucus (Figure 10).
In contrast, SMM treatment of CF cultures
increased the percentage of mucus solids
(Figure 10). These data suggest that SMM
increases airway hydration in normal HBE,
whereas this effect is absent in CF HBE
because of the functional loss of CFTR.
Discussion
CF airways are chronically exposed in vivo
to an intralumenal mucopurulent material
containing host and bacterial products.
Mucous cell metaplasia/hyperplasia is a
hallmark of CF airway epithelia in response
to the infectious and inflammatory airway
milieu. However, the effects of an
intralumenal infectious/inflammatory
milieu on mucus cell hyperplasia, balance
between mucin secretion and proteolysis,
and coordinate fluid transport in normal
versus CF airway epithelia have not been
well characterized.
The relative rates of mucin versus
liquid secretion determine the hydration
status of airway mucus, denominated by the
percent solids content. Importantly, mucus
clearance rates and disease severity scale
inversely to mucus hydration (26, 32, 33).
The present study used human bronchial
epithelial cultures to evaluate the effects of
CF airway lumenal contents (SMM) as a
probe of the inflammatory stress chemically
presented to CF airway surfaces. The effects
of SMM on mucin and liquid secretory
responses of normal versus DF508/DF508
CF cultures and the consequent effects on
mucus hydration were compared.
Acute exposure of normal HBE to
SMM promoted mucin secretion in a dose-
and time-dependent manner (Figures 1 and
2). We speculated that the acute effect of
SMM on mucin secretion was likely caused,
in part, by proteases present in SMM, and a
proteomics analysis identified multiple
proteases in SMM (see Table E2). A
component of CF sputum shown to
stimulate mucin release from airway
epithelia, neutrophil elastase (28, 34), was
identified in SMM. Cathepsin G, also
reported to promote mucin secretion (35),
was also detected in SMM. SMM also
contains MMP-9 (see Table E2). MMP-9
activity is increased during CF pulmonary
exacerbations (29), and it cleaves alpha-1
antitrypsin (36), the major antiprotease of
the lower respiratory tract that inactivates
neutrophil elastase (37). Therefore, MMP-9
may increase the neutrophil elastase activity
in SMM and contribute to increased








































Figure 7. Chronic (72 h) supernatant of mucopurulent material (SMM) treatment of non–cystic
fibrosis (CF) and CF human bronchial epithelial cultures promotes increased mucin secretion.
Accumulated secreted mucins and ATPgS (100 mM)-induced release of intracellular stored mucins
from non-CF (normal) and CF human bronchial epithelial cultures exposed to phosphate-buffered
saline (PBS) (control) or undiluted SMM for 72 hours. The apically accumulated mucins were assayed
by ELISA, using mucin-specific antibodies, as detailed in METHODS. Data represent mean6 SD. n = 5.
*P, 0.05, SMM-exposed non-CF or CF versus control (PBS-treated) cultures. #P, 0.05, CF versus
non-CF cultures exposed to PBS. ATPgS = adenosine 59-O-(3-thio)triphosphate.
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The acute effects of SMM on mucin
secretion likely were also mediated by
intracellular Ca21 mobilization resulting
from activation of purinoceptors in HBE by
nucleotides (11, 38), which are contained in
SMM (14). The concentration of ATP in
SMM is approximately 1 mM, similar to
the ATP levels observed in CF sputum (14).
Notably, mucosal exposure of CF HBE
to 1-mM ATP elicits intracellular Ca21
signals in the 400-nM range (39), which
promotes mucin exocytosis. Other
constituents in SMM, such as ILs, acting
via activation of receptor-dependent
intracellular Ca21 mobilization, and
tumor necrosis factor (TNF)-a may also
be implicated in calcium-mediated
mucin exocytosis (40–42).
Acute SMM exposure also led to
proteolysis of secreted mucins in a dilution-
and time-dependent manner (Figures 1 and
2). This effect was also mediated by
proteases present in SMM (see Table E2),
based on the observation that protease
inhibitors protected secreted mucins from
SMM-induced proteolysis (Figure 3).
These data are in agreement with
previous reports that serine
proteases mediate mucin epitope
proteolysis (43).
Prolonged SMM exposure had large
stimulatory effects on the transcription,
translation, and secretion of MUC5AC
and MUC5B (Figures 4–7). Several
components in SMM are candidates to
upregulate mucin synthesis. For example,
long-term exposure to neutrophil elastase
induces mucous hyperplasia, resulting in a
larger population of mucin-secreting
cells (44). In addition to proteases, SMM
contains bacterial exoproducts and
T-helper cell type 1 cytokines previously
reported in CF secretions, including IL-1b
and TNF-a (see Figure E1). IL-1b, TNF-a,
and LPS increase the expression of
mucins via transcriptional and post-
transcriptional mechanisms, providing
mechanisms for increased mucin production
on a per cell basis (45, 46). The increased
mucin gene transcription was also associated
with increased levels of mucin secretion, with
secretion of MUC5B chronically exceeding
secretion of MUC5AC (Figure 7). This
finding is consistent with the increased basal
mucin secretion caused by increased secretory
cell numbers noted in previous studies (17).
Our data indicate that CF HBE exposed
to SMM exhibit similar mucin secretory
responses as normal HBE exposed to
SMM, whereas fluid secretory responses
differed between normal and CF HBE
exposed to SMM. Three observations
supported this conclusion. First, forskolin-
induced currents (an index of CFTR-
mediated Cl2 secretion) were upregulated
by SMM in normal, but not in CF, HBE
(Figure 8). Second, SMM increased
ASL height in normal, but not in CF,
cultures (Figure 9). Third, the percent of
mucus solids was decreased in normal
HBE following SMM exposure, whereas
the concentration of mucus increased
after SMM exposure in CF cultures
(Figure 10).
These data are pertinent to clinical data
from CF subjects. A key distinction between
sputum from normal versus CF individuals
is the relative difference in airway
dehydration that may reflect the presence
versus absence of functional CFTR in
normal versus CF subjects, respectively.
Mucus concentrations have been reported as
approximately 2% solids in normal subjects
and greater than or equal to 7% solids in CF
subjects (47). Importantly, mucus percent
solids correlate directly with loss of
mucociliary clearance in vitro and in vivo,
and with FEV1 in subjects with chronic

















































































































Figure 8. Effect of supernatant of mucopurulent material (SMM) on the bioelectric properties of
non–cystic fibrosis (CF) and CF human bronchial epithelia. Bioelectric measurements were
conducted in non-CF (normal) and CF human bronchial epithelial cultures, as described in
METHODS. (A and B) Effect of sequential addition of amiloride (Amil.) (300 mM; apical), forskolin
(10 mM; apical), UTP (100 mM; apical), and bumetanide (100 mM; basolateral) on short circuit
currents in non-CF (A) and CF (B) cultures exposed to phosphate-buffered saline (PBS) or SMM for
72 hours. (C) Compiled data from A and B for amiloride-sensitive and forskolin- and UTP-induced
currents. Data represent mean6 SD. n = 8–12. *P, 0.05, SMM-exposed versus control
(PBS-exposed) cultures. ISC = short circuit current; UTP = uridine-59-triphosphate.
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link between the percent solids content and
reduced mucociliary clearance is the mucus
osmotic pressure (8). The greater than or
equal to 7% mucus solids concentrations
in CF generate osmotic pressures predicted
to produce severe compression of the
periciliary liquid layer, with resultant
mucus adhesion and stasis (47). Our data
suggest that normal airways can produce a
more copious but “thin” (transportable)
mucus to capture and flush secretory toxic
materials from the lung, whereas CF
airways fail to generate this adaptive
response.
Our findings might be also relevant to
non-CF bronchiectasis (NCFB), a milder
obstructive disease than CF, as evidenced
most simply by the large difference
in life span between NCFB and CF
subjects. We speculate that the relative
concentrations of mucus may contribute
to the greater severity of CF versus NCFB
lung disease (26). Such a difference in CF
versus NCFB mucus concentrations may
reflect the different mucin versus liquid
secretory responses to the mix of
bacterial and host defense materials in the
airway lumens of NCFB versus CF
subjects. Indeed, NCFB is associated with
less hyperconcentrated mucus than CF
(48, 49), with mucus concentrations
reported as approximately 3–4% solids in
NCFB subjects (47). Osmotic pressures in
the NCFB 3–4% range are predicted to
modestly compress cilia, slow mucus
clearance, and likely produce disease
(8, 47). Studies using primary human
bronchial epithelial cultures and SMM
from NCFB subjects are necessary to
address the integrated mucin and fluid
secretory responses to the intralumenal
mucopurulent materials to test for
quantitative differences between NCFB
and CF airways.
In summary, exposure of human
bronchial epithelial cultures to the
bacterial and host defense products in
SMM produced acute mucin release,
whereas longer term SMM exposure
induced upregulation of mucin
synthesis, storage, and release. These
mucin responses seemed similar in
normal and CF cultures. In contrast,
SMM produced a coordinated CFTR-
mediated Cl2 secretory and ASL
volume responses in normal, but not
in CF, HBE. The absence of the fluid
secretory response in CF produced a
more dehydrated (concentrated)
mucus that is predicted to exacerbate
mucus adhesion and accumulation,
rather than exhibit the normal
hydrating/flushing response as an
adaptive host response. n
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Figure 9. Effect of supernatant of mucopurulent material (SMM) on airway surface liquid (ASL) height
in non–cystic fibrosis (CF) versus CF human bronchial epithelial cultures. (A) Non-CF (normal) and
CF human bronchial epithelial cultures were exposed to phosphate-buffered saline (PBS) or SMM
for 72 hours. ASL height was evaluated as described in METHODS, and is shown as the percentage
increase after treatment with SMM over PBS for both groups. Data represent mean6 SD. n = 5–6.
*P, 0.05, CF versus non-CF cultures. (B) Non-CF human bronchial epithelial cultures were
exposed to SMM for 48 hours and ASL height was evaluated by XZ confocal microscopy.
CFTRInh-172 was added apically as a dry powder in perfluorocarbon and ASL height was
remeasured. ASL height is expressed as percentage inhibition of ASL height by CFTRInh-172
relative to ASL height from PBS- or SMM-treated non-CF human bronchial epithelia.




























Figure 10. Effect of supernatant of
mucopurulent material (SMM) on mucus percent
solids in non–cystic fibrosis (CF) versus CF
human bronchial epithelial cultures. Non-CF
(normal) and CF cultures were exposed to
phosphate-buffered saline or SMM for 72 hours.
Mucus percent solids was evaluated as
described in METHODS. Data represent mean6 SD.
n = 8 for all groups. *P, 0.05, CF versus non-CF
cultures. PBS = phosphate-buffered saline.
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